Contribute
España
Italia
대한민국
日本
Français

Benzinga

Research
My Stocks
Tools
Free Benzinga Pro Trial
SPY
761.930.02%
QQQ
707.830.03%
BTC/USD
77481.250.1146%
DIA
527.670.02%
GLD
396.500.06%
TLT
81.830.05%

Bioceres Crop Solutions Corp

BIOXNASDAQ
Trade with Public
Trade with Public
$0.4599
0.02996.95%
At close: Sep 1, 5:00 PM EST
$0.4590
-0.0009-0.2%
After Hours: 6:43 PM EST
OverviewNewsEarnings ForecastPrice TargetsFinancialsSentimentCompareOptionsStock Report

Bioceres Crop Solutions Analyst Price Targets

Wall Street analyst price targets and consensus rating for Bioceres Crop Solutions (BIOX).

Price Target Range — 10 Quarters

Analyst Consensus — 4 Analysts

3Buy
1Hold
Consensus RatingBuy# Analysts4Avg. Consensus PT$9Upside to Avg. PT+1947.9%

Rating Trend — Last 9 Months

Recent Analyst Actions

See all ratings →
DateFirmAnalystActionRating ChangePrice Target
Jan 2, 2026Canaccord GenuityAustin MoellerPT CutHold$2→$2
Nov 14, 2025Canaccord GenuityAustin MoellerPT CutHold$3→$2
More with Benzinga EdgeGet Access

Analyst Ratings News

Ulta Beauty To Rally Around 16%? Here Are 10 Top Analyst Forecasts For Friday

Avi Kapoor

PRO
Canaccord Genuity Maintains Hold on Bioceres Crop Solutions, Lowers Price Target to $2

Canaccord Genuity analyst Austin Moeller maintains Bioceres Crop Solutions (NASDAQ:BIOX) with a Hold and lowers the price target from $2.25 to $2.
Benzinga Newsdesk

PRO
Canaccord Genuity Maintains Hold on Bioceres Crop Solutions, Lowers Price Target to $2.25

Canaccord Genuity analyst Austin Moeller maintains Bioceres Crop Solutions (NASDAQ:BIOX) with a Hold and lowers the price target from $2.5 to $2.25.
Benzinga Newsdesk

PRO
Lake Street Maintains Buy on Bioceres Crop Solutions, Lowers Price Target to $5

Lake Street analyst Ben Klieve maintains Bioceres Crop Solutions (NASDAQ:BIOX) with a Buy and lowers the price target from $8 to $5.
Benzinga Newsdesk

This HP Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Wednesday

Avi Kapoor

PRO
Canaccord Genuity Downgrades Bioceres Crop Solutions to Hold, Lowers Price Target to $2.5

Canaccord Genuity analyst Austin Moeller downgrades Bioceres Crop Solutions (NASDAQ:BIOX) from Buy to Hold and lowers the price target from $6.5 to $2.5.
Benzinga Newsdesk

Data & APIs: Benzinga APIs · Stock News API · Analyst Ratings API · Company Logo API

Market data provided by Benzinga APIs

Connect With Us
instagramlinkedinyoutubeblueskymastodon
About Benzinga
Market Resources
Trading Tools & Education
Ring the Bell
© 2026 Benzinga | All Rights Reserved